Literature DB >> 15814902

A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy.

M Judith Donovan Post.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15814902      PMCID： PMC7977129     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  12 in total

Review 1.  Delayed developmental effects following prenatal exposure to drugs.

Authors:  A Mantovani; G Calamandrei
Journal:  Curr Pharm Des       Date:  2001-06       Impact factor: 3.116

2.  Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients.

Authors:  A Muñoz; F Mateos; R Simón; M T García-Silva; S Cabello; J Arenas
Journal:  Neuroradiology       Date:  1999-12       Impact factor: 2.804

3.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

Authors:  S Blanche; M Tardieu; P Rustin; A Slama; B Barret; G Firtion; N Ciraru-Vigneron; C Lacroix; C Rouzioux; L Mandelbrot; I Desguerre; A Rötig; M J Mayaux; J F Delfraissy
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

4.  Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.

Authors:  M Gerschenson; S W Erhart; C Y Paik; M C St Claire; K Nagashima; B Skopets; S W Harbaugh; J W Harbaugh; W Quan; M C Poirier
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-01       Impact factor: 2.205

Review 5.  Antiretroviral therapy in pregnancy: a focus on safety.

Authors:  G P Taylor; N Low-Beer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2000-11-01       Impact factor: 3.731

7.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.

Authors:  Béatrice Barret; Marc Tardieu; Pierre Rustin; Catherine Lacroix; Brigitte Chabrol; Isabelle Desguerre; Catherine Dollfus; Marie-Jeanne Mayaux; Stéphane Blanche
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

8.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

9.  Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Authors:  Miriam C Poirier; Rao L Divi; Lena Al-Harthi; Ofelia A Olivero; Vi Nguyen; Brettania Walker; Alan L Landay; Vernon E Walker; Manhattan Charurat; William A Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

10.  Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Authors:  M Culnane; M Fowler; S S Lee; G McSherry; M Brady; K O'Donnell; L Mofenson; S L Gortmaker; D E Shapiro; G Scott; E Jimenez; E C Moore; C Diaz; P M Flynn; B Cunningham; J Oleske
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.